Literature DB >> 20501127

Reduced adenosine deaminase activity in the CNS of spontaneously-hypertensive rats.

L P Davies1, J W Hambley, G A Johnston.   

Abstract

The activity of adenosine deaminase (ADA) has been measured in the hypothalamus, pons medulla and cerebral cortex from 30-day-old and 100-day-old spontaneously-hypertensive rats (SHR) and age-matched WKY controls. At 100 days there was a significant reduction in ADA activity in the hypothalamus (18.0%), pons medulla (20.6%) and cerebral cortex (14.7%). In 30-day-old SHR animals (prior to the development of significant hypertension) no significant changes were seen in the cerebral cortex or pons medulla but there was a small but significant reduction in ADA activity in the hypothalamus (9.2%). There was no significant reduction in the ADA activity in heart or kidney. Extracts of 100-day-old pons medulla which had been briefly heated to destroy endogenous ADA activity did not differentially affect the activity of exogenous purified ADA.

Entities:  

Year:  1987        PMID: 20501127     DOI: 10.1016/0197-0186(87)90081-7

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  2 in total

1.  Caffeine Improves GABA Transport in the Striatum of Spontaneously Hypertensive Rats (SHR).

Authors:  Regina Célia Cussa Kubrusly; Thais da Rosa Valli; Mariana Nunes Marinho Ritter Ferreira; Pâmella de Moura; Vladimir Pedro Peralva Borges-Martins; Robertta Silva Martins; Danielle Dias Pinto Ferreira; Matheus Figueiredo Sathler; Ricardo Augusto de Melo Reis; Gustavo Costa Ferreira; Alex Christian Manhães; Maurício Dos Santos Pereira
Journal:  Neurotox Res       Date:  2021-10-12       Impact factor: 3.911

2.  Ethanol and Caffeine Effects on Social Interaction and Recognition in Mice: Involvement of Adenosine A2A and A1 Receptors.

Authors:  Laura López-Cruz; Noemí San-Miguel; Pilar Bayarri; Younis Baqi; Christa E Müller; John D Salamone; Mercé Correa
Journal:  Front Behav Neurosci       Date:  2016-11-02       Impact factor: 3.558

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.